Try Alerts Free   |   Login
Health Care › Pharmaceutical Preparations

Mirati Therapeutics (MRTX) Financials and Smart Investor 13F Alerts

See how revenue, income, cash flow, and balance sheet financials have changed over 28 quarters since 2014. Compare with MRTX stock chart to see long term trends.

MRTX stock compared to

MRTX Income Statement

Revenue, Net:1707000
Revenue Per Share:0.04
Research & Development Expense:82705000
Total Operating Expenses:108043000
Operating Income:-106336000
Net Income:-101087000
Earnings Per Share, Basic:-2.09
Shares Outstanding, Basic Avg:44987555

MRTX Cash Flow

Operating Activities Net Income:
Net Cash from Operations:-76421000
Net Cash from Financing Activities:889889000
Property, Plant & Equipment Purchases:1506000
Net Cash from Investing Activities:-59340000
Net Change in Cash & Equivalents:754128000

MRTX Balance Sheet

Cash and Cash Equivalents:886182000
Short-Term Investments:504544000
Total Current Assets:1403643000
Property, Plant & Equipment, Net:7809000
Total Assets:1476128000
Accounts Payable:18117000
Total Short-Term Liabilities:71472000
Total Liabilities:115339000

Major Holders (from 13F filings)

Investment Type
Change
Value (x$1000)
increase or decrease
Blackrock Inc.
3,410,886 sh
-36,751 sh
-1%
$566,377
$172,760
Vanguard Group Inc
3,344,122 sh
-105,080 sh
-3%
$555,290
$161,494
Aviva Holdings Ltd.
3,135,966 sh
 
$520,727
FMR LLC
2,485,602 sh
415,077 sh
20%
$412,734
$176,343
Boxer Capital, LLC
1,765,560 sh
 
$293,171
Wellington Management Group Llp
1,637,420 sh
-167,281 sh
-9%
$271,893
$65,851
Sands Capital Management, LLC
1,330,702 sh
-837,870 sh
-39%
$220,963
-$26,623
Sands Capital Management, LLC
1,330,702 sh
-837,870 sh
-39%
$220,963
-$26,623
Orbimed Advisors LLC
1,317,000 sh
-7,100 sh
-1%
$218,688
$67,516
Price T Rowe Associates Inc /Md/
1,311,262 sh
2,410 sh
0%
$217,735
$68,303
Farallon Capital Management LLC
875,000 sh
225,000 sh
35%
$145,294
$71,083
UBS Asset Management Americas Inc
646,296 sh
41,646 sh
7%
$107,317,452
$38,284,562
Goldman Sachs Group Inc
560,103 sh
558,303 sh
31017%
$93,006
$92,800
Invesco Ltd.
513,220 sh
485,943 sh
1782%
$85,220
$82,106
Artal Group S.A.
500,000 sh
500,000 sh
NEW
$83,025
$83,025
Ameriprise Financial Inc
453,437 sh
-45,670 sh
-9%
$75,273
$18,292
Northern Trust Corp
443,297 sh
-19,081 sh
-4%
$73,610
$20,820
Charles Schwab Investment Management Inc
348,328 sh
87,073 sh
33%
$57,840
$28,012
Amundi Pioneer Asset Management Inc
293,970 sh
-70,629 sh
-19%
$48,814
$7,188
Credit Suisse Ag/
191,252 sh
-17,959 sh
-9%
$31,758
$7,873

Data imported from Mirati Therapeutics Inc SEC filings. Check original filings before making any investment decision.